QGEN Qiagen NV

  1. Stocks
  2. Healthcare
  3. NYSE: QGEN

Price (delayed)

$37.08

Market cap

$7.67B

P/E Ratio

19.83

Dividend/share

$2.54

EPS

$1.87

Enterprise value

$8.67B

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 20
Relative Valuation: Rel. Valuation: 79
Relative Profitability: Rel. Profitability: 92

qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from ...

Highlights
The price to earnings (P/E) is 55% lower than the 5-year quarterly average of 43.5 and 20% lower than the last 4 quarters average of 24.2
The gross profit has grown by 32% YoY
Qiagen's quick ratio has decreased by 26% QoQ and by 13% YoY
The debt has grown by 17% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.qiagen.com/
Peers: TMO BDX GE TECH

Key stats

What are the main financial stats of QGEN

QGEN stock price

How has the Qiagen stock price performed over time
Intraday
2.21%
1 week
-0.38%
1 month
5.43%
1 year
-20.62%
YTD
-17.55%
QTD
-7.39%

Financial performance

How have Qiagen's revenue and profit performed over time
Revenue
$2.1B
Gross profit
$1.3B
Operating income
$434.93M
Net income
$402.17M
Gross margin
62%
Net margin
19.2%
The gross profit has grown by 32% YoY
Qiagen's gross margin has increased by 26% YoY
The operating margin has declined by 7% since the previous quarter
Qiagen's operating income has decreased by 7% QoQ

Price vs fundamentals

How does QGEN's price correlate with its fundamentals

Growth

What is Qiagen's growth rate over time

Valuation

What is Qiagen stock price valuation
QGEN P/E details
P/E
19.83
P/B
2.41
P/S
3.66
EV/EBIT
17.56
EV/EBITDA
12.48
EV/Sales
4.13
The price to earnings (P/E) is 55% lower than the 5-year quarterly average of 43.5 and 20% lower than the last 4 quarters average of 24.2
Qiagen's EPS has decreased by 4.6% from the previous quarter
The stock's price to book (P/B) is 21% less than its 5-year quarterly average of 3.0 and 13% less than its last 4 quarters average of 2.7
QGEN's equity is down by 12% QoQ and by 2.2% YoY
QGEN's price to sales (P/S) is 27% lower than its 5-year quarterly average of 4.9 and 22% lower than its last 4 quarters average of 4.6
The company's revenue rose by 4.8% YoY

Efficiency

How efficient is Qiagen business performance
Qiagen's ROS has soared by 164% YoY but it has decreased by 6% from the previous quarter
The company's return on invested capital has surged by 150% YoY but it fell by 7% QoQ
QGEN's return on assets is down by 6% since the previous quarter
QGEN's ROE is down by 5% from the previous quarter

Dividends

What is QGEN's dividend history
DPS
$2.54
Dividend yield
6.85%
Payout ratio
135.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Qiagen financials performed over time
Qiagen's total assets is 136% higher than its total liabilities
Qiagen's quick ratio has decreased by 26% QoQ and by 13% YoY
The current ratio is down by 18% from the previous quarter and by 4.7% YoY
The debt is 51% smaller than the equity
Qiagen's debt to equity has increased by 20% YoY and by 11% from the previous quarter
The debt has grown by 17% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.